Yesterday in New York City GE Healthcare unveiled a new $1 billion initiative to fund innovative cancer research in a variety of cancer fields.
The initial focus is on breast cancer thanks to $100 million, raised with help from a few venture capital funds, that will fund an open innovation challenge that seeks to identify promising new approaches to improve breast cancer diagnostics.
Additionaly, GE unveiled an impressive portable mammography concept as part of a portfolio of integrated technologies aimed at combating cancer. The SenoCase is mobile mammography system which can be folded and easily stored in a car boot. According to GE, such portability could remove geographical barriers to regular breast screening for many women on a global scale. The system could also be more cost effective than conventional mammography systems, making it more accessible to smaller practices and clinics.
According to the SenoCase fact-sheet, GE hopes to include:
- A standard field of view Cesium Iodide detector
- Similar image quality to a full-field digital mammography system
- A user-friendly interface, operable by a single clinician
It would be nice to see some rugged prototypes emerging from this initial concept. We’ll keep you posted.

More from GE: GE Launches New Commitment to Accelerate Cancer Fight





Researchers from the University of Missouri have developed a nanotechnology sensor for the early diagnosis of lung cancer. In the latest issue of Nature Nanotechnology they have published their findings and views on how it can contribute to medicine.
Artificially engineered body parts are a hot area of biomedical sciences these days, but up until now, most synthetic organs aren’t much more than expensive, anatomically correct props for medical and crime scene TV shows. That’s because there hasn’t been a way to supply artificial tissue with the nutrients needed for them to function and interact with living tissue. Our bodies utilize tiny, complex systems of blood vessels to keep our organs running, but artificially reproducing these networks of capillaries has proven to be seemingly impossible.
Researchers at Stanford University used functional MRI to detect when people were experiencing pain by detecting changing blood flow patterns in the brain. Because pain, almost by definition, has always been a subjective phenomenon, judging its true nature is difficult as some people are more tolerant of it than others.
Carestream Health, Inc. has announced the launch of its new DRX-Revolution Mobile X-Ray System, which incorporates a number of improvements to existing portable X-Ray systems.
Researchers from the Mayo Clinic have developed a new way to combat 

Siesta Medical out of Los Gatos, California won FDA approval for its Encore Tongue Suspension System for treatment of obstructive sleep apnea.
Neuroptics Inc. from Irvine, California released the VIP-200 Pupillometer, a hand-held device to screen patients for refractive surgery. The device helps eye surgeons to optimize patients for a laser-assisted in situ keratomileusis (LASIK) procedures and fitting of multifocal intraocular lenses (IOLs). The Pupillometer can simulate scotopic, low mesopic and high mesopic light conditions and measure them in one run of 10 seconds. This makes it possible to customize pupil dependent IOLs better to patient preferences. A golf pro who needs to see best during day light or a radiologist who is reporting from a dimly lit room can be tested for their personal needs.




